Axa’s Cavium, Inc. CAVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-35,000
| Closed | -$3.03M | – | 1436 |
|
|
2018
Q2 | $3.03M | Hold |
35,000
| – | – | 0.01% | 759 |
|
|
2018
Q1 | $2.78M | Sell |
35,000
-25,000
| -42% | -$2.18M | 0.01% | 792 |
|
|
2017
Q4 | $5.03M | Buy |
60,000
+7,000
| +13% | +$542K | 0.02% | 651 |
|
|
2017
Q3 | $3.5M | Buy |
53,000
+6,000
| +13% | +$380K | 0.02% | 717 |
|
|
2017
Q2 | $2.92M | Buy |
47,000
+7,000
| +18% | +$489K | 0.01% | 718 |
|
|
2017
Q1 | $2.87M | Hold |
40,000
| – | – | 0.01% | 705 |
|
|
2016
Q4 | $2.5M | Hold |
40,000
| – | – | 0.01% | 721 |
|
|
2016
Q3 | $2.33M | Hold |
40,000
| – | – | 0.01% | 719 |
|
|
2016
Q2 | $1.54M | Sell |
40,000
-100,000
| -71% | -$4.95M | 0.01% | 782 |
|
|
2016
Q1 | $8.56M | Sell |
140,000
-1,000
| -0.7% | -$57.7K | 0.04% | 429 |
|
|
2015
Q4 | $9.27M | Sell |
141,000
-154,134
| -52% | -$10.4M | 0.04% | 403 |
|
|
2015
Q3 | $18.1M | Sell |
295,134
-8,880
| -3% | -$592K | 0.07% | 260 |
|
|
2015
Q2 | $20.9M | Sell |
304,014
-15,325
| -5% | -$1.07M | 0.08% | 247 |
|
|
2015
Q1 | $22.6M | Sell |
319,339
-36,366
| -10% | -$2.36M | 0.09% | 239 |
|
|
2014
Q4 | $22M | Sell |
355,705
-45,340
| -11% | -$2.4M | 0.09% | 246 |
|
|
2014
Q3 | $19.9M | Sell |
401,045
-51,476
| -11% | -$2.61M | 0.09% | 261 |
|
|
2014
Q2 | $22.5M | Sell |
452,521
-166,241
| -27% | -$7.65M | 0.09% | 246 |
|
|
2014
Q1 | $27.1M | Sell |
618,762
-246
| -0% | -$9.67K | 0.12% | 204 |
|
|
2013
Q4 | $21.4M | Buy |
619,008
+44,535
| +8% | +$1.67M | 0.1% | 237 |
|
|
2013
Q3 | $23.7M | Sell |
574,473
-64,290
| -10% | -$2.42M | 0.12% | 203 |
|
|
2013
Q2 | $22.6M | Buy |
+638,763
| New | +$21.3M | 0.12% | 193 |
|
Axa's CAVM Position: Q3 2018 in Review
Axa sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 35,000 shares — an estimated $3.03M sold.
Axa first reported a position in CAVM in Q2 2013 and held it in 21 quarters. The position peaked at $27.1M in Q1 2014. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.
- Axa reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
- Axa sold 35,000 Cavium, Inc. shares in Q3 2018, an estimated $3.03M.
- Axa first reported a position in Cavium, Inc. in Q2 2013 and held it in 21 quarters.
- Axa's Cavium, Inc. position peaked at $27.1M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.
Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.